Federal Grand Jury Probes Merck’s Handling of Vioxx

& Co. is the subject of a federal grand-jury probe into its and practices for , the painkiller it pulled from the market in 2004, according to a person familiar with the matter.

The health-care-fraud unit of the U.S. Attorney’s Office for the District of Massachusetts is investigating whether promoted to health-care professionals for uses other than those approved by government regulators, a practice known as off-label , this person said.

Learn More: Wall Street Journal

Popularity: 46% [?]

There Is 1 Response So Far. »

  1. [...] Federal Grand Jury Probes Merck’s Handling of Vioxx Office for the District of Massachusetts is investigating whether Merck promoted Vioxx to health-care professionals for uses other than those… [...]

Post a Response


Breaking News | Consumer Fraud | Dangers to the Environment | Defective Drugs

Defective Medical Devices | Other Defective Products | Vaccines

© Copyright Defective Products Lawyer 2007. All rights reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Attorney Advertising